EP3370759 - COMBINATION THERAPY OF AN HBV CAPSID ASSEMBLY INHIBITOR AND AN INTERFERON [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 12.02.2021 Database last updated on 13.11.2024 | |
Former | Examination is in progress Status updated on 14.06.2019 | ||
Former | Request for examination was made Status updated on 10.08.2018 | ||
Former | The international publication has been made Status updated on 13.05.2017 | ||
Former | unknown Status updated on 11.11.2016 | Most recent event Tooltip | 12.02.2021 | Application deemed to be withdrawn | published on 17.03.2021 [2021/11] | Applicant(s) | For all designated states F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH | [2018/37] | Inventor(s) | 01 /
GAO, Lu Building 5 No. 720 Cailun Road Shanghai 201203 / CN | 02 /
NAJERA, Isabel c/o F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH | 03 /
SHEN, Hong Building 5 No. 720 Cailun Road Shanghai 201203 / CN | 04 /
SHEN, Fang Building 5 No. 720 Cailun Road Shanghai 201203 / CN | 05 /
SHI, Liping Building 5 No. 720 Cailun Road Shanghai 201203 / CN | 06 /
WILDUM, Steffen c/o F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH | 07 /
YANG, Guang Building 5 No. 720 Cailun Road Shanghai 201203 / CN | [2018/37] | Representative(s) | Sauer, Frank F. Hoffmann-La Roche AG Patent Department Grenzacherstrasse 124 4070 Basel / CH | [2018/37] | Application number, filing date | 16790332.7 | 31.10.2016 | [2018/37] | WO2016EP76195 | Priority number, date | WO2015CN93688 | 03.11.2015 Original published format: PCT/CN2015/093688 | [2018/37] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017076791 | Date: | 11.05.2017 | Language: | EN | [2017/19] | Type: | A1 Application with search report | No.: | EP3370759 | Date: | 12.09.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 11.05.2017 takes the place of the publication of the European patent application. | [2018/37] | Search report(s) | International search report - published on: | EP | 11.05.2017 | Classification | IPC: | A61K38/21, A61K31/506, A61P31/20 | [2018/37] | CPC: |
A61K31/506 (EP,KR,US);
A61K31/5377 (EP,US);
A61K38/212 (EP,KR,US);
A61P31/12 (EP,US);
A61P31/22 (KR);
A61K2300/00 (KR,US)
| C-Set: |
A61K31/506, A61K2300/00 (EP,US);
A61K38/212, A61K2300/00 (US,EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/37] | Title | German: | KOMBINATIONSTHERAPIE EINES HBV-KAPSID-ANORDNUNGSINHIBITORS UND EINES INTERFERONS | [2018/37] | English: | COMBINATION THERAPY OF AN HBV CAPSID ASSEMBLY INHIBITOR AND AN INTERFERON | [2018/37] | French: | POLYTHÉRAPIE AU MOYEN D'UN INHIBITEUR D'ENSEMBLE CAPSIDE HBV ET D'UN INTERFÉRON | [2018/37] | Entry into regional phase | 04.06.2018 | National basic fee paid | 04.06.2018 | Designation fee(s) paid | 04.06.2018 | Examination fee paid | Examination procedure | 03.04.2018 | Date on which the examining division has become responsible | 04.06.2018 | Examination requested [2018/37] | 18.12.2018 | Amendment by applicant (claims and/or description) | 19.06.2019 | Despatch of a communication from the examining division (Time limit: M04) | 21.10.2019 | Reply to a communication from the examining division | 18.03.2020 | Despatch of a communication from the examining division (Time limit: M06) | 29.09.2020 | Application deemed to be withdrawn, date of legal effect [2021/11] | 22.10.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2021/11] | Fees paid | Renewal fee | 08.10.2018 | Renewal fee patent year 03 | 11.10.2019 | Renewal fee patent year 04 | 09.10.2020 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO0145712 (BAYER AG [DE], et al) [X] 1,12-14,16,27,31-33* Formula (I); page 3, lines 17-24; page 69, lines 11-18; page 80, lines 8-12;; example -; claim - *; | [XDI]WO2014037480 (HOFFMANN LA ROCHE [CH], et al) [XD] 1,2,12-14,16,17,27-33 * Formula (I); page 87, lines 11-13;; example -; claim - * [I] 1-3,8-33; | [XDI]WO2014184328 (HOFFMANN LA ROCHE [CH], et al) [XD] 1,4,12-14,16,17,27-33 * Formula (I); page 92, lines 9-11;; example -; claim - * [I] 1,4,5,8-33; | [XDI]WO2015132276 (HOFFMANN LA ROCHE [CH], et al) [XD] 1,6,12-14,16,17,27-33 * Formula (I); page 58, lines 12-14;; example -; claim - * [I] 1,6-33 |